Astonishing Labs partners with university lab scientists to commercialize groundbreaking biotech research that utilizes electrical signaling for organ growth and cancer treatment without genetic intervention. This approach addresses the slow progress in transforming early-stage scientific discoveries into viable biotech companies, aiming to create therapies with broad implications for various diseases.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The translation of early-stage biotech research into viable companies and therapies is a slow and challenging process. Many promising scientific discoveries with broad therapeutic potential struggle to progress beyond academic labs.
Solution
Astonishing Labs partners directly with university scientists to commercialize groundbreaking biotech research, focusing on areas like organ growth and cancer treatment using electrical signaling rather than genetic intervention. This approach aims to accelerate the development of platform companies built upon revolutionary science. By investing at the earliest stages of innovation, Astonishing Labs identifies and supports scientists challenging established dogmas to create therapies with broad implications across various diseases and patient populations. They focus on discovering fundamental biological truths applicable across multiple disciplines, leading to differentiated approaches in treating diseases and transforming modern medicine.
Target Audience
Astonishing Labs targets investors interested in early-stage biotech companies and scientists with groundbreaking research in electrical signaling for therapeutic applications.
Features
- Focus on commercializing research utilizing electrical signaling for therapeutic applications.
- Partnership model directly with university labs to build platform companies.
- Investment in early-stage research to accelerate the translation of discoveries into viable therapies.
- Development of therapies that do not rely on genetic intervention.